Retractable Technologies, Inc. (NYSEAMERICAN:RVP) posted its earnings results on Tuesday. The company reported ($0.01) earnings per share for the quarter, Bloomberg Earnings reports. Retractable Technologies had a negative return on equity of 22.24% and a negative net margin of 17.65%.
Retractable Technologies (RVP) traded up $0.05 during trading on Wednesday, reaching $0.67. The company’s stock had a trading volume of 333,700 shares, compared to its average volume of 150,514. Retractable Technologies has a one year low of $0.54 and a one year high of $2.59.
In other Retractable Technologies news, insider Thomas J. Shaw purchased 1,000,000 shares of Retractable Technologies stock in a transaction dated Wednesday, August 23rd. The shares were acquired at an average cost of $0.57 per share, with a total value of $570,000.00. Following the completion of the transaction, the insider now owns 13,065,642 shares in the company, valued at approximately $7,447,415.94. The transaction was disclosed in a filing with the SEC, which is available at this link. Over the last ninety days, insiders have bought 1,096,381 shares of company stock worth $631,383.
Retractable Technologies Company Profile
Retractable Technologies, Inc designs, develops and manufactures safety medical products for the healthcare industry. The Company markets VanishPoint and PatientSafe products. The VanishPoint products are designed specifically to prevent needle stick injuries and to prevent reuse. The VanishPoint safety products include tuberculin, insulin and allergy antigen VanishPoint syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL and 10mL VanishPoint syringes, and the VanishPoint autodisable syringe.
Receive News & Ratings for Retractable Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Retractable Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.